[{"id":"8577f9f8-3299-4ebb-ba9e-c93e03ca96c0","acronym":"","url":"https://clinicaltrials.gov/study/NCT05523947","created_at":"2022-09-01T13:59:30.741Z","updated_at":"2024-07-02T16:34:37.982Z","phase":"Phase 1/2","brief_title":"Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor","source_id_and_acronym":"NCT05523947","lead_sponsor":"Yuhan Corporation","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • nesfrotamig (ABL105)"],"overall_status":"Recruiting","enrollment":" Enrollment 137","initiation":"Initiation: 08/26/2022","start_date":" 08/26/2022","primary_txt":" Primary completion: 10/01/2026","primary_completion_date":" 10/01/2026","study_txt":" Completion: 12/01/2026","study_completion_date":" 12/01/2026","last_update_posted":"2024-06-05"}]